PRESS RELEASE published on 09/03/2024 at 07:00, 1 year 5 months ago Valneva et Pfizer annoncent de nouvelles données positives de Phase 2 après une vaccination de rappel pour le candidat vaccin contre la maladie de Lyme Valneva et Pfizer rapportent des données positives de Phase 2 pour le candidat vaccin contre la maladie de Lyme, montrant une forte réponse immunitaire post-vaccination de rappel Valneva Phase 2 Maladie De Lyme Pfizer Vaccin
PRESS RELEASE published on 09/03/2024 at 07:00, 1 year 5 months ago Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidate Valneva and Pfizer announce positive Phase 2 booster results for Lyme disease vaccine candidate, VLA15-221, showing strong immune response and safety profile, advancing towards Phase 3 trials Valneva Phase 2 Lyme Disease Vaccine Pfizer Immunogenicity
BRIEF published on 08/30/2024 at 11:06, 1 year 5 months ago Franchissement de seuil pour Valneva SE Droits De Vote Franchissement De Seuil Marché Des Actions Valneva SE Groupe Grimaud
BRIEF published on 08/30/2024 at 11:06, 1 year 5 months ago Valneva SE Crosses Threshold Voting Rights Stock Market Valneva SE Threshold Crossing Grimaud Group
PRESS RELEASE published on 08/30/2024 at 11:01, 1 year 5 months ago Franchissement de seuil Déclaration de franchissement de seuil par Groupe Grimaud La Corbière pour VALNEVA SE Déclaration Franchissement De Seuil AMF Valneva SE Groupe Grimaud La Corbière
PRESS RELEASE published on 08/22/2024 at 10:51, 1 year 5 months ago Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research GmbH hat ein Research Update zu Valneva SE veröffentlicht. Analyst Simon Scholes behält seine Kaufempfehlung bei und bestätigt das Kursziel von EUR 8,60 First Berlin Equity Research Research Update Kaufempfehlung Aktienanalyse Valneva
BRIEF published on 08/20/2024 at 16:06, 1 year 5 months ago First Berlin Equity Research Reiterates Buy Rating for Valneva SE Valneva Equity Research Market Undervaluation H1 Results Lyme Vaccine
BRIEF published on 08/20/2024 at 16:06, 1 year 5 months ago First Berlin Equity Research réitère sa recommandation d'achat pour Valneva SE Valneva Recherche Sur Les Actions Vaccin Contre La Maladie De Lyme Sous-évaluation Du Marché Résultats H1
PRESS RELEASE published on 08/20/2024 at 16:01, 1 year 5 months ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research GmbH updates research on Valneva SE (ISIN: FR0004056851) with a BUY recommendation and EUR 8.60 price target. H1 product sales slightly below consensus but gross margin improving. Valneva maintains full-year guidance First Berlin Equity Research Buy Recommendation Valneva SE EUR 8.60 Price Target H1 Product Sales
BRIEF published on 08/13/2024 at 07:05, 1 year 5 months ago Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates Financial Results Cash Position Revenue Guidance Valneva Vaccine Development
Published on 02/05/2026 at 00:00, 27 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 2 hours 2 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 8 hours 12 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 8 hours 42 minutes ago Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 20:54, 3 hours 33 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 3 hours 51 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 4 hours 27 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 5 hours 32 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 5 hours 47 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 6 hours 23 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 6 hours 23 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 6 hours 42 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 6 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL